• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于拟合的结直肠癌筛查的最佳截断值:一项观察性研究。

The optimal cut-off value in fit-based colorectal cancer screening: An observational study.

机构信息

Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

Cancer Med. 2021 Mar;10(5):1872-1879. doi: 10.1002/cam4.3761. Epub 2021 Feb 3.

DOI:10.1002/cam4.3761
PMID:33534955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7940214/
Abstract

BACKGROUND

Colorectal cancer (CRC) screening programs using fecal immunochemical test (FIT) have to choose a cut-off value to decide which citizens to recall for colonoscopy. The evidence on the optimal cut-off value is sparse and based on studies with a low number of cancer cases.

METHODS

This observational study used data from the Danish Colorectal Cancer Screening Database. Sensitivity and specificity were estimated for various cut-off values based on a large number of cancers. Traditionally optimal cut-off values are found by weighting sensitivity and specificity equally. As this might result in too many unnecessary colonoscopies we also provide optimal cut-off values for different weighting of sensitivity and specificity/number of needed colonoscopies to detect one cancer.

RESULTS

Weighting sensitivity and specificity equally gives an optimal cut-off value of 45 ng Hb/ml. This, however, means making 24 colonoscopies to detect one cancer. Weighting sensitivity lower and for example, aiming at making about 16 colonoscopies to detect one cancer, gives an optimal cut-off value of 125 ng Hb/ml.

CONCLUSIONS

The optimal cut-off value in an FIT population-based screening program is 45 ng Hb/ml, when as traditionally sensitivity and specificity are weighted equally. If, however, 24 colonoscopies needed to detect one cancer is too huge a burden on the health care system and the participants, 80, 125, 175, and 350 ng Hb/ml are optimal cut-off values when only 19/16/14/10 colonoscopies are accepted to find one cancer.

摘要

背景

使用粪便免疫化学检测(FIT)的结直肠癌(CRC)筛查计划必须选择一个截止值来决定召回哪些公民进行结肠镜检查。关于最佳截止值的证据很少,并且基于癌症病例数量较少的研究。

方法

本观察性研究使用了丹麦结直肠癌筛查数据库的数据。根据大量癌症病例,估计了各种截止值的敏感性和特异性。传统上,通过对敏感性和特异性进行同等加权来找到最佳截止值。由于这可能导致过多不必要的结肠镜检查,我们还提供了不同敏感性和特异性/需要进行结肠镜检查以检测一个癌症的数量加权的最佳截止值。

结果

对敏感性和特异性进行同等加权得到的最佳截止值为 45ng Hb/ml。然而,这意味着要进行 24 次结肠镜检查才能检测到一个癌症。如果降低敏感性并例如,旨在进行约 16 次结肠镜检查以检测一个癌症,则最佳截止值为 125ng Hb/ml。

结论

在基于 FIT 的人群筛查计划中,最佳截止值为 45ng Hb/ml,此时传统上敏感性和特异性加权相等。然而,如果进行 24 次结肠镜检查以检测一个癌症的负担对医疗保健系统和参与者来说太大,则当仅接受 19/16/14/10 次结肠镜检查来发现一个癌症时,80、125、175 和 350ng Hb/ml 是最佳截止值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/f7bb4d102c27/CAM4-10-1872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/6a2cb9892b8a/CAM4-10-1872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/4b654bbe7661/CAM4-10-1872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/f7bb4d102c27/CAM4-10-1872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/6a2cb9892b8a/CAM4-10-1872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/4b654bbe7661/CAM4-10-1872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7940214/f7bb4d102c27/CAM4-10-1872-g002.jpg

相似文献

1
The optimal cut-off value in fit-based colorectal cancer screening: An observational study.基于拟合的结直肠癌筛查的最佳截断值:一项观察性研究。
Cancer Med. 2021 Mar;10(5):1872-1879. doi: 10.1002/cam4.3761. Epub 2021 Feb 3.
2
Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.荷兰结直肠癌筛查计划第一年中实时监测结果以及通过调整粪便免疫化学检测截断值进行优化
Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24.
3
Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.粪便免疫化学试验在结直肠癌筛查中的应用:不同截断值的结肠镜检查结果。
J Gastroenterol Hepatol. 2019 Jan;34(1):103-112. doi: 10.1111/jgh.14373. Epub 2018 Jul 29.
4
Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme.在一项企业结直肠癌筛查项目中对一种新型免疫粪便潜血检测的最佳截断点进行评估。
J Med Screen. 1996;3(2):66-71. doi: 10.1177/096914139600300204.
5
Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.在结直肠癌的组织筛查项目中,不同截断值下单次免疫化学检测的诊断收益。
Eur J Cancer. 2013 Aug;49(12):2727-33. doi: 10.1016/j.ejca.2013.03.023. Epub 2013 Apr 16.
6
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.荷兰结直肠癌筛查项目第二轮:粪便免疫化学检测截断值提高对筛查效果的影响。
Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9.
7
A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.基于人群的免疫化学粪便潜血试验用于结直肠癌筛查的比较。
Gastroenterology. 2013 May;144(5):918-25. doi: 10.1053/j.gastro.2013.01.042. Epub 2013 Feb 1.
8
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.基于人群的结直肠癌筛查计划中,粪便免疫化学试验采用性别特异性截断值时的间隔期癌症。
J Med Screen. 2022 Sep;29(3):156-165. doi: 10.1177/09691413221085218. Epub 2022 Mar 8.
9
Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.粪便免疫化学试验检测结直肠癌的最佳截断值与年龄和性别有关。
PLoS One. 2021 Jul 16;16(7):e0254021. doi: 10.1371/journal.pone.0254021. eCollection 2021.
10
Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs.粪便免疫化学试验用于结直肠癌筛查的性别特异性截断值:基于人群的结肠镜检查结果和成本研究。
J Med Screen. 2021 Dec;28(4):439-447. doi: 10.1177/09691413211020035. Epub 2021 Jun 9.

引用本文的文献

1
Introducing colon capsule endoscopy as a new diagnostic modality for patients with bowel symptoms in general practice: a feasibility study.在全科医疗中引入结肠胶囊内镜作为肠道症状患者的一种新诊断方法:一项可行性研究。
BMC Prim Care. 2025 May 14;26(1):159. doi: 10.1186/s12875-025-02864-4.
2
Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights.探索 5G 支持下家庭胶囊内镜的可行性:创新与碳足迹洞察。
BMJ Open Gastroenterol. 2024 Oct 31;11(1):e001500. doi: 10.1136/bmjgast-2024-001500.
3
Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.

本文引用的文献

1
Three years of colorectal cancer screening in Denmark.丹麦的三年结直肠癌筛查。
Cancer Epidemiol. 2018 Dec;57:39-44. doi: 10.1016/j.canep.2018.09.003. Epub 2018 Oct 4.
2
Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.丹麦全国队列研究:结直肠癌筛查对检出早期疾病的效果。
Gastroenterology. 2018 Jul;155(1):99-106. doi: 10.1053/j.gastro.2018.03.062. Epub 2018 Apr 5.
3
Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test.
用 ROC 曲线测定肺癌肿瘤标志物筛查。
Dis Markers. 2024 Mar 21;2024:4782618. doi: 10.1155/2024/4782618. eCollection 2024.
4
Clinical performance study of a fecal bacterial signature test for colorectal cancer screening.粪便细菌标志物检测用于结直肠癌筛查的临床性能研究。
PLoS One. 2023 Nov 22;18(11):e0293678. doi: 10.1371/journal.pone.0293678. eCollection 2023.
5
Clinical utility of colon capsule endoscopy: a moving target?结肠胶囊内镜的临床应用:一个不断变化的目标?
Therap Adv Gastroenterol. 2023 Oct 9;16:17562848231195680. doi: 10.1177/17562848231195680. eCollection 2023.
6
Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer.磁共振成像前列腺分区与肿瘤形态学参数预测前列腺癌肿瘤分期诊断
Diagn Interv Radiol. 2023 Nov 7;29(6):753-760. doi: 10.4274/dir.2023.232284. Epub 2023 Oct 3.
7
Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer.粪便微生物组合panel 早期检测结直肠癌患者的鉴别能力的准确性。
J Gastrointest Cancer. 2024 Mar;55(1):332-343. doi: 10.1007/s12029-023-00962-z. Epub 2023 Aug 11.
8
Could tumour volume and major and minor axis based on CTA statistical anatomy improve the pre-operative T-stage in oesophageal cancer?基于 CTA 统计解剖的肿瘤体积和长、短轴是否可以提高食管癌的术前 T 分期?
Cancer Med. 2023 Jul;12(13):14037-14051. doi: 10.1002/cam4.6051. Epub 2023 Jun 12.
9
Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma.基于原发性肺腺癌脊柱转移对表皮生长因子受体(EGFR)突变及亚型预测的综合分析。
Front Oncol. 2023 Apr 18;13:1154327. doi: 10.3389/fonc.2023.1154327. eCollection 2023.
10
Colon Capsule Endoscopy in the Diagnosis of Colon Polyps: Who Needs a Colonoscopy?结肠胶囊内镜在结肠息肉诊断中的应用:谁需要进行结肠镜检查?
Diagnostics (Basel). 2022 Aug 29;12(9):2093. doi: 10.3390/diagnostics12092093.
选择粪便免疫化学检测用于结直肠癌筛查的临界值。
Clin Transl Gastroenterol. 2017 Aug 3;8(8):e111. doi: 10.1038/ctg.2017.37.
4
The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from Thailand.在结肠镜检查资源有限的国家中,用于结直肠癌筛查的粪便免疫化学检测的最佳临界值:一项来自泰国的多中心研究
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):405-412. doi: 10.22034/APJCP.2017.18.2.405.
5
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.免疫化学粪便潜血试验对近端和远端进展期肿瘤同样敏感。
Am J Gastroenterol. 2012 Oct;107(10):1570-8. doi: 10.1038/ajg.2012.249. Epub 2012 Jul 31.
6
The Danish Pathology Register.丹麦病理学登记处。
Scand J Public Health. 2011 Jul;39(7 Suppl):72-4. doi: 10.1177/1403494810393563.
7
The Danish National Patient Register.丹麦国家患者登记处。
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482.
8
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).基于人群的结直肠癌筛查中免疫化学粪便潜血试验最佳临界值确定的成本效益分析(KCIS 16)
J Med Screen. 2007;14(4):191-9. doi: 10.1258/096914107782912022.
9
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies.晚期腺瘤进展为结直肠癌的风险按年龄和性别划分:基于840,149例结肠镜筛查的估计值。
Gut. 2007 Nov;56(11):1585-9. doi: 10.1136/gut.2007.122739. Epub 2007 Jun 25.
10
Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population.在一般平均风险人群中,评估一种具有自动判读功能的免疫化学粪便潜血试验用于结直肠癌筛查的效果。
Int J Cancer. 2005 Jun 20;115(3):493-6. doi: 10.1002/ijc.20921.